Home Newsfeeds SVB Leerink Downgrades AVEO Pharmaceuticals to Market Perform

SVB Leerink Downgrades AVEO Pharmaceuticals to Market Perform

SVB Leerink analyst Andrew Berens downgrades AVEO Pharmaceuticals (NASDAQ:AVEO) from Outperform to Market Perform.

byBenzinga Newsdesk

October 24, 2022

1 minute read

SVB Leerink analyst Andrew Berens downgrades AVEO Pharmaceuticals (NASDAQ:AVEO) from Outperform to Market Perform.

Is Gold the New Safe Haven? Investors Flock To Precious Metals As Prices Soar Close To All-Time High

By Benzinga Neuro

April 9, 2:03 AM

Gold prices are inching closer to an all-time high as investors anxiously await the release of key US data and minutes from the Federal Reserve's recent policy meeting.

KRRGF

Middlefield Banc Corp. Announces 2023 Q4 Cash Dividend Payment And Declares A $0.05 Special Cash Dividend Payment

By Benzinga Newsdesk

November 14, 9:23 AM

Middlefield Banc Corp. (NASDAQ:MBCN) today announced that its Board of Directors declared a special cash dividend of $0.05 per common share and a regular quarterly cash dividend of $0.20 per common share. Both dividends

MBCN